CYTH
Price
$1.61
Change
+$0.01 (+0.62%)
Updated
Mar 1, 6:59 PM EST
9 days until earnings call
PTPI
Price
$1.67
Change
-$0.05 (-2.91%)
Updated
Mar 1, 6:59 PM EST
Ad is loading...

Compare predictions CYTH vs PTPI

Header iconCYTH vs PTPI Comparison
Open Charts CYTH vs PTPIBanner chart's image
Cyclo Therapeutics
Price$1.61
Change+$0.01 (+0.62%)
Volume$12.06K
CapitalizationN/A
Petros Pharmaceuticals
Price$1.67
Change-$0.05 (-2.91%)
Volume$371.52K
CapitalizationN/A
View a ticker or compare two or three
CYTH vs PTPI Comparison Chart

Loading...

CYTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PTPIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CYTH vs. PTPI commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTH is a Hold and PTPI is a Hold.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (CYTH: $1.61 vs. PTPI: $1.67)
Brand notoriety: CYTH and PTPI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CYTH: 15% vs. PTPI: 34%
Market capitalization -- CYTH: $46.03M vs. PTPI: $3.79M
CYTH [@Pharmaceuticals: Other] is valued at $46.03M. PTPI’s [@Pharmaceuticals: Other] market capitalization is $3.79M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $87.37B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTH’s FA Score shows that 0 FA rating(s) are green whilePTPI’s FA Score has 0 green FA rating(s).

  • CYTH’s FA Score: 0 green, 5 red.
  • PTPI’s FA Score: 0 green, 5 red.
According to our system of comparison, PTPI is a better buy in the long-term than CYTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTH’s TA Score shows that 3 TA indicator(s) are bullish while PTPI’s TA Score has 7 bullish TA indicator(s).

  • CYTH’s TA Score: 3 bullish, 6 bearish.
  • PTPI’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PTPI is a better buy in the short-term than CYTH.

Price Growth

CYTH (@Pharmaceuticals: Other) experienced а -8.00% price change this week, while PTPI (@Pharmaceuticals: Other) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.25%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +39.76%.

Reported Earning Dates

CYTH is expected to report earnings on May 14, 2024.

PTPI is expected to report earnings on Mar 31, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+0.25% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CYTH with price predictions.
OPEN
A.I.dvisor published
a Summary for PTPI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTH($46M) has a higher market cap than PTPI($3.79M). PTPI YTD gains are higher at: 18.440 vs. CYTH (1.258). PTPI has higher annual earnings (EBITDA): -8.76M vs. CYTH (-19.36M). PTPI has more cash in the bank: 18M vs. CYTH (1.8M). CYTH has less debt than PTPI: CYTH (45.2K) vs PTPI (8.69M). PTPI has higher revenues than CYTH: PTPI (6.99M) vs CYTH (952K).
CYTHPTPICYTH / PTPI
Capitalization46M3.79M1,215%
EBITDA-19.36M-8.76M221%
Gain YTD1.25818.4407%
P/E RatioN/AN/A-
Revenue952K6.99M14%
Total Cash1.8M18M10%
Total Debt45.2K8.69M1%
FUNDAMENTALS RATINGS
CYTH vs PTPI: Fundamental Ratings
CYTH
PTPI
OUTLOOK RATING
1..100
6241
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTPI's Valuation (38) in the Medical Specialties industry is in the same range as CYTH (64) in the null industry. This means that PTPI’s stock grew similarly to CYTH’s over the last 12 months.

PTPI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CYTH (100) in the null industry. This means that PTPI’s stock grew similarly to CYTH’s over the last 12 months.

PTPI's SMR Rating (98) in the Medical Specialties industry is in the same range as CYTH (100) in the null industry. This means that PTPI’s stock grew similarly to CYTH’s over the last 12 months.

PTPI's Price Growth Rating (50) in the Medical Specialties industry is in the same range as CYTH (50) in the null industry. This means that PTPI’s stock grew similarly to CYTH’s over the last 12 months.

PTPI's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as CYTH (100) in the null industry. This means that PTPI’s stock grew similarly to CYTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTHPTPI
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CYTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PTPIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDRX1.360.09
+7.09%
Biodexa Pharmaceuticals plc
ZLAB21.100.12
+0.57%
Zai Lab Limited
TXRH149.600.23
+0.15%
Texas Roadhouse
MSBI23.90-0.43
-1.77%
Midland States Bancorp
GSIT3.60-0.57
-13.60%
GSI Technology

CYTH and

Correlation & Price change

A.I.dvisor tells us that CYTH and ACB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYTH and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTH
1D Price
Change %
CYTH100%
N/A
ACB - CYTH
24%
Poorly correlated
+0.96%
RDHL - CYTH
24%
Poorly correlated
-8.08%
CGC - CYTH
22%
Poorly correlated
-2.73%
AVDL - CYTH
21%
Poorly correlated
+7.61%
PTPI - CYTH
21%
Poorly correlated
-2.91%
More

PTPI and

Correlation & Price change

A.I.dvisor tells us that PTPI and ESPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTPI and ESPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTPI
1D Price
Change %
PTPI100%
-2.91%
ESPR - PTPI
29%
Poorly correlated
+1.59%
RDHL - PTPI
26%
Poorly correlated
-8.08%
SNDL - PTPI
25%
Poorly correlated
+2.22%
ACET - PTPI
23%
Poorly correlated
+2.35%
LFCR - PTPI
23%
Poorly correlated
+0.84%
More